HER2（ErbB2）Antibodies Market Report

Global and Region HER2（ErbB2）Antibodies Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：148
  • REPORT CODE：GMM993512
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of HER2（ErbB2）Antibodies market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of HER2（ErbB2）Antibodiesmarket, defines the market attractiveness level of HER2（ErbB2）Antibodies market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of HER2（ErbB2）Antibodies industry, describes the types of HER2（ErbB2）Antibodies market, the applications of major players and the market size, and deeply analyzes the current situation of the global HER2（ErbB2）Antibodies market and the development prospects and opportunities of HER2（ErbB2）Antibodies industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global HER2（ErbB2）Antibodies market in Chapter 13.

    By Player:

    • Bio-Techne (Novus Biologicals, LLC)

    • Cell Signaling Technology (CST)

    • BioVision Inc,

    • Atlas Antibodies

    • Biocon Limited

    • Genentech Inc (F Hoffmann-La Roche Ltd)

    • Celltrion Inc

    • Novartis AG

    • Pfizer Inc

    • Thermo Fisher Scientific

    • InvivoGen

    • Abnova Corporation

    • Proteintech Group Inc

    By Type:

    • Trastuzumab

    • Lapatinib

    • Ado-trastuzumab emtansine

    • Pertuzumab

    • Everolimus

    By End-User:

    • Hospitals

    • Clinics

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 HER2（ErbB2）Antibodies Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 HER2（ErbB2）Antibodies Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 HER2（ErbB2）Antibodies Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 HER2（ErbB2）Antibodies Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise HER2（ErbB2）Antibodies Market Analysis and Outlook to 2022

    • 7.1 Global HER2（ErbB2）Antibodies Consumption (2017-2022)

    • 7.2 United States HER2（ErbB2）Antibodies Consumption (2017-2022)

    • 7.3 Europe HER2（ErbB2）Antibodies Consumption (2017-2022)

    • 7.4 China HER2（ErbB2）Antibodies Consumption (2017-2022)

    • 7.5 Japan HER2（ErbB2）Antibodies Consumption (2017-2022)

    • 7.6 India HER2（ErbB2）Antibodies Consumption (2017-2022)

    • 7.7 South Korea HER2（ErbB2）Antibodies Consumption (2017-2022)

    8 Region and Country-wise HER2（ErbB2）Antibodies Market Analysis and Outlook to 2028

    • 8.1 Global HER2（ErbB2）Antibodies Consumption Forecast (2022-2028)

    • 8.2 United States HER2（ErbB2）Antibodies Consumption Forecast (2022-2028)

    • 8.3 Europe HER2（ErbB2）Antibodies Consumption Forecast (2022-2028)

    • 8.4 China HER2（ErbB2）Antibodies Consumption Forecast (2022-2028)

    • 8.5 Japan HER2（ErbB2）Antibodies Consumption Forecast (2022-2028)

    • 8.6 India HER2（ErbB2）Antibodies Consumption Forecast (2022-2028)

    • 8.7 South Korea HER2（ErbB2）Antibodies Consumption Forecast (2022-2028)

    9 Global HER2（ErbB2）Antibodies Market Outlook by Types and Applications to 2022

    • 9.1 Global HER2（ErbB2）Antibodies Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Trastuzumab Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Lapatinib Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Ado-trastuzumab emtansine Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Pertuzumab Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Everolimus Consumption and Growth Rate (2017-2022)

    • 9.2 Global HER2（ErbB2）Antibodies Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

    10 Global HER2（ErbB2）Antibodies Market Outlook by Types and Applications to 2028

    • 10.1 Global HER2（ErbB2）Antibodies Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Trastuzumab Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Lapatinib Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Ado-trastuzumab emtansine Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Pertuzumab Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Everolimus Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global HER2（ErbB2）Antibodies Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    11 Global HER2（ErbB2）Antibodies Import and Export Analysis (Top 5 Countries)

    • 11.1 Global HER2（ErbB2）Antibodies Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global HER2（ErbB2）Antibodies Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 HER2（ErbB2）Antibodies Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global HER2（ErbB2）Antibodies Market Competitive Analysis

    • 14.1 Bio-Techne (Novus Biologicals, LLC)

      • 14.1.1 Bio-Techne (Novus Biologicals, LLC) Company Details

      • 14.1.2 Bio-Techne (Novus Biologicals, LLC) HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Bio-Techne (Novus Biologicals, LLC) HER2（ErbB2）Antibodies Product and Service

    • 14.2 Cell Signaling Technology (CST)

      • 14.2.1 Cell Signaling Technology (CST) Company Details

      • 14.2.2 Cell Signaling Technology (CST) HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Cell Signaling Technology (CST) HER2（ErbB2）Antibodies Product and Service

    • 14.3 BioVision Inc,

      • 14.3.1 BioVision Inc, Company Details

      • 14.3.2 BioVision Inc, HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 BioVision Inc, HER2（ErbB2）Antibodies Product and Service

    • 14.4 Atlas Antibodies

      • 14.4.1 Atlas Antibodies Company Details

      • 14.4.2 Atlas Antibodies HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Atlas Antibodies HER2（ErbB2）Antibodies Product and Service

    • 14.5 Biocon Limited

      • 14.5.1 Biocon Limited Company Details

      • 14.5.2 Biocon Limited HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Biocon Limited HER2（ErbB2）Antibodies Product and Service

    • 14.6 Genentech Inc (F Hoffmann-La Roche Ltd)

      • 14.6.1 Genentech Inc (F Hoffmann-La Roche Ltd) Company Details

      • 14.6.2 Genentech Inc (F Hoffmann-La Roche Ltd) HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Genentech Inc (F Hoffmann-La Roche Ltd) HER2（ErbB2）Antibodies Product and Service

    • 14.7 Celltrion Inc

      • 14.7.1 Celltrion Inc Company Details

      • 14.7.2 Celltrion Inc HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Celltrion Inc HER2（ErbB2）Antibodies Product and Service

    • 14.8 Novartis AG

      • 14.8.1 Novartis AG Company Details

      • 14.8.2 Novartis AG HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Novartis AG HER2（ErbB2）Antibodies Product and Service

    • 14.9 Pfizer Inc

      • 14.9.1 Pfizer Inc Company Details

      • 14.9.2 Pfizer Inc HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Pfizer Inc HER2（ErbB2）Antibodies Product and Service

    • 14.10 Thermo Fisher Scientific

      • 14.10.1 Thermo Fisher Scientific Company Details

      • 14.10.2 Thermo Fisher Scientific HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Thermo Fisher Scientific HER2（ErbB2）Antibodies Product and Service

    • 14.11 InvivoGen

      • 14.11.1 InvivoGen Company Details

      • 14.11.2 InvivoGen HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 InvivoGen HER2（ErbB2）Antibodies Product and Service

    • 14.12 Abnova Corporation

      • 14.12.1 Abnova Corporation Company Details

      • 14.12.2 Abnova Corporation HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Abnova Corporation HER2（ErbB2）Antibodies Product and Service

    • 14.13 Proteintech Group Inc

      • 14.13.1 Proteintech Group Inc Company Details

      • 14.13.2 Proteintech Group Inc HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Proteintech Group Inc HER2（ErbB2）Antibodies Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of HER2（ErbB2）Antibodies

    • Figure HER2（ErbB2）Antibodies Picture

    • Table Global HER2（ErbB2）Antibodies Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global HER2（ErbB2）Antibodies Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global HER2（ErbB2）Antibodies Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global HER2（ErbB2）Antibodies Consumption by Country (2017-2022)

    • Figure United States HER2（ErbB2）Antibodies Consumption and Growth Rate (2017-2022)

    • Table Europe HER2（ErbB2）Antibodies Consumption and Growth Rate (2017-2022)

    • Figure China HER2（ErbB2）Antibodies Consumption and Growth Rate (2017-2022)

    • Figure Japan HER2（ErbB2）Antibodies Consumption and Growth Rate (2017-2022)

    • Figure India HER2（ErbB2）Antibodies Consumption and Growth Rate (2017-2022)

    • Figure South Korea HER2（ErbB2）Antibodies Consumption and Growth Rate (2017-2022)

    • Figure Global HER2（ErbB2）Antibodies Consumption Forecast by Country (2022-2028)

    • Figure United States HER2（ErbB2）Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe HER2（ErbB2）Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure China HER2（ErbB2）Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan HER2（ErbB2）Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure India HER2（ErbB2）Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea HER2（ErbB2）Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Trastuzumab Consumption and Growth Rate (2017-2022)

    • Figure Global Lapatinib Consumption and Growth Rate (2017-2022)

    • Figure Global Ado-trastuzumab emtansine Consumption and Growth Rate (2017-2022)

    • Figure Global Pertuzumab Consumption and Growth Rate (2017-2022)

    • Figure Global Everolimus Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Trastuzumab Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lapatinib Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ado-trastuzumab emtansine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pertuzumab Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Everolimus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Table Global HER2（ErbB2）Antibodies Import by Region (Top 5 Countries) (2017-2028)

    • Table Global HER2（ErbB2）Antibodies Export by Region (Top 5 Countries) (2017-2028)

    • Table Bio-Techne (Novus Biologicals, LLC) (Foundation Year, Company Profile and etc.)

    • Table Bio-Techne (Novus Biologicals, LLC) HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bio-Techne (Novus Biologicals, LLC) HER2（ErbB2）Antibodies Product and Service

    • Table Cell Signaling Technology (CST) (Foundation Year, Company Profile and etc.)

    • Table Cell Signaling Technology (CST) HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cell Signaling Technology (CST) HER2（ErbB2）Antibodies Product and Service

    • Table BioVision Inc, (Foundation Year, Company Profile and etc.)

    • Table BioVision Inc, HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioVision Inc, HER2（ErbB2）Antibodies Product and Service

    • Table Atlas Antibodies (Foundation Year, Company Profile and etc.)

    • Table Atlas Antibodies HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Atlas Antibodies HER2（ErbB2）Antibodies Product and Service

    • Table Biocon Limited (Foundation Year, Company Profile and etc.)

    • Table Biocon Limited HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biocon Limited HER2（ErbB2）Antibodies Product and Service

    • Table Genentech Inc (F Hoffmann-La Roche Ltd) (Foundation Year, Company Profile and etc.)

    • Table Genentech Inc (F Hoffmann-La Roche Ltd) HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech Inc (F Hoffmann-La Roche Ltd) HER2（ErbB2）Antibodies Product and Service

    • Table Celltrion Inc (Foundation Year, Company Profile and etc.)

    • Table Celltrion Inc HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celltrion Inc HER2（ErbB2）Antibodies Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG HER2（ErbB2）Antibodies Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc HER2（ErbB2）Antibodies Product and Service

    • Table Thermo Fisher Scientific (Foundation Year, Company Profile and etc.)

    • Table Thermo Fisher Scientific HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific HER2（ErbB2）Antibodies Product and Service

    • Table InvivoGen (Foundation Year, Company Profile and etc.)

    • Table InvivoGen HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table InvivoGen HER2（ErbB2）Antibodies Product and Service

    • Table Abnova Corporation (Foundation Year, Company Profile and etc.)

    • Table Abnova Corporation HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abnova Corporation HER2（ErbB2）Antibodies Product and Service

    • Table Proteintech Group Inc (Foundation Year, Company Profile and etc.)

    • Table Proteintech Group Inc HER2（ErbB2）Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Proteintech Group Inc HER2（ErbB2）Antibodies Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US